TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent…
STOCKHOLM, SE / ACCESSWIRE / April 4, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…
The World Hepatitis Summit (WHS) 2024 Will Bring Together Global Experts to Discuss the Latest Advances in Hepatitis Prevention, Diagnosis…
CHICAGO, IL / ACCESSWIRE / April 3, 2024 / The American College of Osteopathic Family Physicians (ACOFP) announces its new…
Campaign underscores the urgency and need to support early career osteopathic family physicians.CHICAGO, IL / ACCESSWIRE / April 3, 2024…
LAS VEGAS, NV / ACCESSWIRE / April 3, 2024 / Reveal Lasers, a burgeoning force in the aesthetics industry, proudly…
Deeper integration unlocks powerful Weave features to improve patient experiencesLEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one experience platform for…
CAMBRIDGE, MA / ACCESSWIRE / April 3, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that interim data for a first-in-human,…
SOMERVILLE, NJ / ACCESSWIRE / April 3, 2024 / LPW Training Services, a global industry leader in Pharmaceutical and Life…
HOUSTON, TX / ACCESSWIRE / April 3, 2024 / CLS Health, a leader in comprehensive healthcare services, is proud to…